miR ‐17‐3p promotes the proliferation of multiple myeloma cells by downregulating P21 expression through LMLN inhibition-Reference-Cited by-同舟云学术

miR ‐17‐3p promotes the proliferation of multiple myeloma cells by downregulating P21 expression through LMLN inhibition

Published:2021-03 Issue:12 Volume:148 Page:3071-3085
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Xiang Pu¹,Yeung Yiu To²,Wang Jiheng³,Wu Qiong²⁴,Du Ruijuan²⁴,Huang Chuntian²⁴,Jia Xuechao²⁴,Gao Yunfeng²,Zhi Yafei²⁴,Guo Fangqin⁴,Wei Huifang²⁴,Zhang Dandan²,Liu Yuzhang¹,Liu Lina¹,Liang Lijie¹,Wang Juan¹,Song Yongping¹,Liu Kangdong²⁴⁵^ORCID,Fang Baijun¹^ORCID

Affiliation:

1. Department of Hematology Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Henan Hematology Institute Zhengzhou Henan China

2. China‐US (Henan) Hormel Cancer Institute Zhengzhou Henan China

3. Department of Head and Neck Thyroid Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital Zhengzhou Henan China

4. Department of Pathophysiology, School of Basic Medical Sciences Zhengzhou University Zhengzhou Henan China

5. Cancer Chemoprevention International Collaboration Laboratory Zhengzhou Henan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33528

Reference53 articles.

1. Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back

2. Haematological cancer and quality of life: a systematic literature review

3. Consolidation and Maintenance Therapies for Newly Diagnosed Multiple Myeloma in the Era of Novel Agents

4. Long-Term Follow-Up of Autotransplantation Trials for Multiple Myeloma: Update of Protocols Conducted by the Intergroupe Francophone du Myelome, Southwest Oncology Group, and University of Arkansas for Medical Sciences

5. A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of miR-17-3p on K562 cell proliferation and erythroid differentiation as well as γ-globin expression in patients with β-thalassemiar;2024-01-18

2. The Role of MicroRNAs in Mature B-Cell Neoplasias Drug Resistance;Reference Module in Biomedical Sciences;2024

3. Four differentially expressed exosomal miRNAs as prognostic biomarkers and therapy targets in endometrial cancer: Bioinformatic analysis;Medicine;2023-08-25

4. Comprehensive analysis of ferroptosis-related genes in immune infiltration and prognosis in multiple myeloma;Frontiers in Pharmacology;2023-08-07

5. Comparison of Oncogenes, Tumor Suppressors, and MicroRNAs Between Schizophrenia and Glioma: The Balance of Power;Neuroscience & Biobehavioral Reviews;2023-08